Literature DB >> 26231169

Milestones along the road of infection prevention in Egypt.

H A El-Mahallawy1, L M Mohsen2, M Wassef2.   

Abstract

Sequela of infectious diseases include not only morbidity and mortality, but are also associated with chronic illnesses that has long constituted public health problems and huge economic burdens. This review gives a brief idea about important infectious diseases (ID) in Egypt, the main lines taken to combat them, the challenges still existing, and the possible barriers keeping IDs still forming threats to the community. Egypt has the highest prevalence rates of HCV infection worldwide. Significant evidence points towards that the HCV epidemic was initiated and propagated by the anti-schistosomal mass campaigns during the last century. Though the rates of HCV infection are declining, still the decline has not yet met the full expectations. Therefore, infection control programs are gaining more ground all over the country, especially with the growing problem of antimicrobial resistance complicating healthcare-associated infections (HAI) worldwide. Also, mass immnunization of childhood, mycobacterial tuberculosis infections, and avian influenza will be discussed.

Entities:  

Mesh:

Year:  2015        PMID: 26231169     DOI: 10.1007/s10096-015-2444-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  From katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia.

Authors:  P Jordan
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

Review 2.  Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.

Authors:  G Thomas Strickland
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  Global health: a uniquely Egyptian epidemic.

Authors:  Mohammed Yahia
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 4.  Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.

Authors:  Nathan Ford; Kasha Singh; Graham S Cooke; Edward J Mills; Tido von Schoen-Angerer; Adeeba Kamarulzaman; Philipp du Cros
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

5.  CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings.

Authors:  Nevine Fam; Véronique Leflon-Guibout; Salwa Fouad; Laila Aboul-Fadl; Estelle Marcon; Doaa Desouky; Inas El-Defrawy; Aisha Abou-Aitta; John Klena; Marie-Hélène Nicolas-Chanoine
Journal:  Microb Drug Resist       Date:  2010-12-04       Impact factor: 3.431

6.  Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Authors:  Khaled AbdulQawi; Ahmed Youssef; Mohamed A Metwally; Ibrahim Ragih; Mohamed AbdulHamid; AbdulAziz Shaheen
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

Review 7.  Hepatitis C genotype 4: What we know and what we don't yet know.

Authors:  Sanaa M Kamal; Imad A Nasser
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 8.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

9.  Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale.

Authors:  Mary Linehan; Christy Hanson; Angela Weaver; Margaret Baker; Achille Kabore; Kathryn L Zoerhoff; Dieudonne Sankara; Scott Torres; Eric A Ottesen
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

10.  Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.

Authors:  Shaaban H Ahmed; Enas A Daef; Mohammed S Badary; Mohammed A Mahmoud; Alaa A Abd-Elsayed
Journal:  BMC Res Notes       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.